Myeloid Panel (next generation sequencing)
Category | Specialist Integrated Haematological Malignancy Diagnostic Service (SIHMDS) >> Molecular Pathology |
---|---|
Test background |
The Oncomine Myeloid NGS panel is comprised of 40 key genes to cover the most relevant targets in major myeloid disorders. This assay covers the following: Full genes - ASXL1, BCOR, CALR, CEBPA, ETV6, EZH2, IKZF1, NF1, PHF6, PRPF8, RB1, RUNX1, SH2B3, STAG2, TET2, TP53, ZRSR2. |
Clinical Indications |
For diagnostic, prognostic and predictive testing in myeloid disorders including acute myeloid leukaemia (AML) and myeloid dysplastic syndrome (MDS). |
Sample & container required | >1ml bone marrow in EDTA. For other sample types, please liaise with the laboratory. |
Turnaround time | 21 calendar days |